By Catherine Eckford2024-01-18T12:15:51
Challenges such as market exclusivity and patient treatment preference are expected to shape the insomnia and Gaucher disease therapy landscape in the seven major markets (7MM) in 2032, research predicts.
Already a member? Sign-in
European Pharmaceutical Review delivers authoritative insights, cutting-edge innovations, and expert perspectives that not only inform decisions but drive measurable progress across quality, compliance, and operational excellence.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-06-16T10:59:00Z
2026-06-15T07:55:00Z
Sponsored by Octave, By Adam Cross
2026-06-04T09:36:00Z
2025-12-03T07:58:01
Sponsored by MBV AG
2026-04-14T12:32:00
Sponsored by Thermo Fisher Scientific
2026-02-25T15:00:00
Sponsored by Particle Measuring Systems
2026-05-27T13:00:00 2026-05-27T14:00:00
Sponsored by TA Instruments
2025-09-17T08:00:00
Sponsored by Mastercontrol
2026-02-09T10:00:00 2026-02-09T11:00:00
Sponsored by Emerson
Site powered by Webvision Cloud